Detalhe da pesquisa
1.
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
Blood
; 137(22): 3093-3104, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598693
2.
Renal Extramedullary Hematopoiesis in Mast Cell Leukemia with Bone Marrow Fibrosis.
Case Rep Hematol
; 2024: 3502887, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38213502
3.
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma.
Blood Adv
; 5(9): 2391-2402, 2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33950175
4.
Authentication of Primary Murine Cell Lines by a Microfluidics-Based Lab-On-Chip System.
Biomedicines
; 8(12)2020 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33317212
5.
Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From Germany.
Hemasphere
; 6(9): e759, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35966764
6.
getITD for FLT3-ITD-based MRD monitoring in AML.
Leukemia
; 33(10): 2535-2539, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31089248
7.
Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 53(5): 640-643, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29335621